Blog In the News Press Releases Menu Blog In the News Press Releases Home / Sandoz Inc. Recalls One Lot of Losartan Potassium and Hydrochlorothiazide Tablets Due to NDEA Impurities in API Sandoz Inc. Recalls One Lot of Losartan Potassium and Hydrochlorothiazide Tablets Due to NDEA Impurities in API According to the U.S. Food and Drug Administration (FDA), Sandoz Inc. issued a voluntary nationwide recall on one lot of Losartan Potassium Hydrochlorothiazide tablets, USP 100mg/25mg on Friday, November 9…. Read All Global Disruptions Recent Global Disruptions EIGHTEENTH UPDATE: Supply Chain Disruptions Continue as Coronavirus Outbreak Worsens Read More Fire Engulfs Truck Carrying Fiat Spare Parts in Canapi, Sertao Alagoano, Brazil Read More Lactalis to Close its Milk Facility in Rockhampton, Queensland, Australia Read More
